Live Chat

CFD:er är komplexa instrument som innebär hög risk att du förlorar pengar snabbt på grund av hävstången. 74% av icke-professionella investerares konton förlorar pengar när de handlar med CFD:er hos den här leverantören. Du bör överväga om du förstår hur CFD:er fungerar och om du har råd att ta den höga risken att förlora dina pengar.

Close

Affär Bayer BAYGn

Bayer realtidsdiagram

Instrumentfundament

Weekly Search
Weekly
Daily
Datum Stäng Förändring Förändring (%) Öppna Hög Låg

Senaste nyheter

Frances Wang 2024 Dec 17, 16:00

Tesla stock hits new high: Why is TSLA stock is up today?

TSLA
Frances Wang 2024 Dec 17, 16:00

What is the FTSE 100: FTSE 100 analysis for European investors

Indices
Frances Wang 2024 Dec 17, 16:00

Nikkei 225 performance today: Beginner’s guide to Japan’s stock market

Indices Stocks
Frances Wang 2024 Dec 16, 16:00

MicroStrategy Stock Price: MSTR stock saw an increase of 0.15% today

Stocks
Frances Wang 2024 Dec 16, 16:00

Gold price today: gold holds two-day decline ahead of Fed rate cut

Commodities Gold
Frances Wang 2024 Dec 16, 16:00

Latest cryptocurrency news: What is bitcoin, Ethereum explained

Cryptocurrencies
Frances Wang 2024 Dec 15, 16:00

Broadcom stock price soars 23% as AI revenues spike 220%

Stocks
Dyogenes Diniz 2024 Dec 15, 16:00

Morning Note: Tesla Hits Record High Amid US PMI Focus and Bitcoin's Next Move

Cryptocurrencies US500 EUR USD

Info

Spread

0.12

Spread (%)

0.6243 %

Hävstångseffekt

1:5

Köp till dagslåneränta

-0.0556 %

Sälj till dagslåneränta

-0.0333 %

Valuta

EUR

Handelstider

Marknaden är öppen

Onsdag

08:02 - 11:59

Måndag

08:02-11:59

Måndag

12:04-16:29

Tisdag

08:02-11:59

Tisdag

12:04-16:29

Torsdag

08:02-11:59

Torsdag

12:04-16:29

Fredag

08:02-11:59

Fredag

12:04-16:29

Analys och statistik

Öppna

---

Föregående stängning

---

52 veckors högsta/lägsta

--- – ---

Marknadsvärde

19155302400

Utelöpande aktier

982424000

Rapportdatum (nästa)

2018-06-06

Utd-procent

Datum efter utdelning

2024-04-29

Förväntad framtida årlig utdelningsprocent

0.11

Förväntad framtida årlig direktavkastning

0.0056

Vinst per aktie

-0.89

Läs mer om detta instrument

Bayer Bayer AG NA
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment provides breeding, propagation, and production/processing of seeds, including seed dressing. It has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases; and collaboration and license agreement with Cytokinetics for the development and commercialization of aficamten. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Läs mer om detta instrument

Tillgång
Sälj
Köp
Förändring (%)
Relaterade instrument
Trustpilot
Live Chat